Diagnosis of coccidioidomycosis using serum specimens
Complement Fixation (CF)/Immunodiffusion (ID)
Coccidioides antibody, S
San Joaquin Valley fever
Valley Fever
Cocci
Serum
This test is a confirmatory assay for positive screening tests (ie, enzyme immunoassay).
The recommended test to evaluate for possible Coccidioides infection is COXIS / Coccidioides Antibody Screen with Reflex, Serum.
Supplies: Sarstedt Aliquot Tube 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1.8 mL
Collection Instructions: Centrifuge and aliquot serum into plastic vial.
If not ordering electronically, complete, print, and send Infectious Disease Serology Test Request (T916) with the specimen.
1.2 mL
Gross hemolysis | Reject |
Gross lipemia | Reject |
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 14 days |
Diagnosis of coccidioidomycosis using serum specimens
Coccidioidomycosis (valley fever, San Joaquin Valley fever) is a fungal infection found in the Southwestern US, Central America, and South America. It is acquired by inhalation of arthroconidia of Coccidioides immitis/posadasii. Usually, it is a mild, self-limiting pulmonary infection. Less commonly, chronic pneumonia may occur, progressing to fibronodular, cavitary disease. A rash often develops within a day or 2, followed by erythema nodosum or multiforme and accompanying arthralgias. About 2 weeks after exposure, symptomatic patients develop fever, cough, malaise, and anorexia; chest pain is often severe. Coccidioidomycosis may disseminate beyond the lungs to involve multiple organs, including the meninges.
IgG antibody is detected by the complement-fixation tests. Precipitating antibodies (IgM and IgG) are detected by immunodiffusion. They are rarely found in cerebrospinal fluid; however, their presence is associated with meningitis. Chronic coccidioidal pulmonary cavities are often accompanied by IgG and IgM precipitating antibodies.
Serologic testing for coccidioidomycosis should be considered when patients exhibit symptoms of pulmonary or meningeal infection and have lived or traveled in areas where C immitis/posadasii is endemic. Any history of exposure to the organism or travel cannot be overemphasized when a diagnosis of coccidioidomycosis is being considered.
Complement Fixation: Negative
If positive, results are titered.
Immunodiffusion: Negative
Results are reported as positive, negative, or equivocal.
Complement Fixation:
Titer results of 1:2 or higher may suggest active disease; however, titers may persist for months after infection has resolved. Increasing complement fixation (CF) titer results in serial specimens are considered diagnostic of active disease.
Immunodiffusion:
The presence of IgM antibodies may be detectable within 2 weeks after the onset of symptoms; however, the antibody may be detected longer than 6 months after infection.
The presence of IgG antibodies parallels the CF antibodies and may suggest an active or a recent asymptomatic infection with Coccidioides immitis/posadasii; however, antibodies may persist after the infection has resolved.
An equivocal result (a band of nonidentity) cannot be interpreted as significant for a specific diagnosis. However, this may be an indication that a patient should be followed serologically.
Over 90% of primary symptomatic cases will be detected by combined immunodiffusion and CF testing.
Antibodies (both IgM and IgG) may be present after the infection
1. McHardy IH, Barker B, Thompson GR 3rd. Review of clinical and laboratory diagnostics for coccidioidomycosis. J Clin Microbiol. 2023;61(5):e0158122. doi:10.1128/jcm.01581-22
2. Ramanan P, Wengenack NL, Theel ES. Laboratory diagnosis for fungal infections: a review of current and future diagnostic assays. Clin Chest Med. 2017;38(3):535-554. doi:10.1016/j.ccm.2017.04.013
Complement Fixation:
Antibody to coccidioidin in the patient's serum is quantitated by complement fixation (CF). The CF test is a 2-stage test based on the ability of antigen-antibody complexes to bind complement (C'). In the first stage, antigen and antibody combine and fix C'. The second stage is an indicator system in which sheep erythrocytes, sensitized by rabbit anti-sheep red cell antibody (hemolysin), are used to demonstrate the presence of unfixed C'. If the patient's serum contains C'-fixing antibody that reacts with the specific antigen (a positive reaction), C' will be fixed and excess C' will not be available to react with and lyse the sensitized sheep erythrocytes. If no antigen-antibody reaction occurs (a negative reaction), C' will be available to lyse the sheep erythrocytes. The CF titer is determined by the greatest dilution of serum (antibody) in which the sheep erythrocytes are not lysed.(Kaufman L, Kovacs JA, Reiss E. Immunomycology. In: Rose NR, de Macario ED, Folds JD, Lane HC, Nakamura RM, eds. Manual of Clinical Laboratory Immunology. 5th ed. ASM Press; 1997:591-592; Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990;3:247-268; Ramanan P, Wengenack NL, Theel ES. Laboratory diagnosis for fungal infections. A review of current and future diagnostic assays. Clin Chest Med. 2017;38[3]:535-554. doi:10.1016/j.ccm.2017.04.013)
Immunodiffusion:
Immunodiffusion (ID) is a qualitative test employed for the detection of precipitating antibodies present in the serum. Soluble antigens of the fungus are placed in wells of an agarose gel filled Petri dish and the patient's serum and a control (positive) serum are placed in adjoining wells. If present, specific precipitate antibody will form precipitin lines between the wells. Their comparison to the control serum establishes the results. When performing the ID test, only precipitin bands of identity with the reference bands are significant.(Kaufman L, Kovacs JA, Reiss E. Immunomycology. In: Rose NR, Macario ED, Folds JD, Lane HC, Nakamura RM, eds. Manual of Clinical Laboratory Immunology. 5th ed. ASM Press; 1997:591-593; Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990;3[3]:247-268. doi:10.1128/CMR.3.3.247; Ramanan P, Wengenack NL, Theel ES. Laboratory diagnosis for fungal infections. A review of current and future diagnostic assays. Clin Chest Med. 2017;38[3]:535-554)
Monday through Friday
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.
86635 x 3
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
SCOC | Coccidioides Ab, CompF/ImmDiff, S | 87435-4 |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
8295 | Coccidioides Ab, CompF, S | In Process |
21649 | Coccidioides, IgG, ImmDiff, S | 62459-3 |
21648 | Coccidioides, IgM, ImmDiff, S | 62458-5 |